Moreover, because oral iron is poorly absorbed in the setting of ongoing inflammation [21], IBD patients with increased C-reactive protein (CRP) levels often show a diminished response to oral iron therapy [115]. The gene discussed is CRP; the disease is inflammatory bowel disease.